A SNP-by-SNP Approach Could Leave One Clueless

Image: Courtesy of Stephen B. Liggett UN-BALANCING ACT: The figure depicts linkage disequilibrium between ß2-AR SNPS. Genotypes from Caucasians were determined at 13 loci and the degree of linkage disequilibrium between SNPs was calculated. The site at -406 was monomorphic in the Caucasian sample. The promise of pharmacogenetics will not be realized easily. To date, most studies have focused on individual SNPs (single nucleotide polymorphisms), or perhaps a few, but none have consi

Written byJim Kling
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The promise of pharmacogenetics will not be realized easily. To date, most studies have focused on individual SNPs (single nucleotide polymorphisms), or perhaps a few, but none have considered the potentially complex interactions between SNPs on the same gene. That one-at-a-time approach could cause researchers to miss important clues, says Stephen B. Liggett, professor of medicine and molecular genetics, University of Cincinnati College of Medicine. Liggett and his team published results in this Hot Paper showing that multiple SNPs on a single gene can cause functional changes.1

Liggett says he was puzzled by studies such as one involving the a2-adrenergic receptor, which resides on the surfaces of the smooth muscle cells of the respiratory airway, where it regulates airway diameter. It is also the target of beta-agonists that are used to treat asthma. But much individual variability exists in treatment response, prompting researchers to investigate whether SNPs in the receptor's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies